Accessibility setting


Select language

Skip to secondary menu

Skip to content

Jehovah’s Witnesses


Beta Thalassemia (Adults)

Beta Thalassemia Intermedia and Minor—Supportive Therapies and Procedures

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients.

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Source‎: Am J Hematol 2013;88(6):503-6.

Indexed‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital.

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Source‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Indexed‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

Iron overload in β-thalassemia intermedia: an emerging concern.

Musallam KM, Cappellini MD, Taher AT.

Source‎: Curr Opin Hematol 2013;20(3):187-92.

Indexed‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

Therapeutic roles of curcumin: lessons learned from clinical trials.

Gupta SC, Patchva S, Aggarwal BB.

Source‎: AAPS J 2013;15(1):195-218.

Indexed‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension.

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Source‎: Blood 2012;120(7):1531-2.

Indexed‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

Iron out for nontransfused thalassemia.

Marks PW.

Source‎: Blood 2012;120(5):928-9.

Indexed‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study.

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Source‎: J Med Assoc Thai 2012;95(1):29-36.

Indexed‎: PubMed 22379738

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.